TES and ovarian carcinoma: TES has been identified as a TSG in many types of tumors, such as uterine cancer [7], ovarian carcinoma [17], breast cancer [18], endometrial carcinoma [19], head and neck squamous cell carcinoma [20], and non-small cell lung cancer [21].